Tech Company Inital Public Offerings
Lantern Pharma IPO
Lantern Pharma was acquired by . Lantern Pharma shares were listed on 6/11/2020.
Transaction Overview
Company Name
Announced On
6/11/2020
Transaction Type
IPO
Amount
$25,000,000
Proceeds Purpose
Use of proceeds for the Lantern Pharma IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1920 McKinney Ave. 7th Floor
Dallas, TX 75201
USA
Dallas, TX 75201
USA
Phone
Website
Email Address
Overview
Lantern develops novel targeted cancer therapeutics. Lantern identifies, acquires and advances de-risked, value embedded drug leads towards clinical success for unmet cancer needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Panna Sharma
Chief Financial Officer
David Margrave
Chief Scientific Officer
Kishor Bhatia
Co-Founder
Peter Nara
Browse more venture capital transactions:
Prev: 6/11/2020: Domino Data Lab venture capital transaction
Next: 6/11/2020: Viaduct venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs